Ibuprofen Brillpharma (Ireland) (Ibuprofen)

Ibuprofen blocks the cyclooxygenase‑1 and cyclooxygenase‑2 enzymes, which are essential for converting arachidonic acid into prostaglandins. By lowering prostaglandin levels, it diminishes pain signals, reduces fever, and curtails inflammation at the site of tissue injury or infection.

The appropriate dose of Ibuprofen Brillpharma is determined by the prescribing healthcare professional based on the patient’s age, weight, clinical condition, and response to therapy. Patients should follow the prescriber’s instructions and the product labeling.

Safety of ibuprofen during pregnancy and lactation depends on the trimester and individual risk factors. Generally, ibuprofen is avoided in the third trimester and used with caution earlier. Breastfeeding mothers should consult their physician, as small amounts may be excreted in milk.

To place an order, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Ibuprofen shares the core mechanism of COX inhibition with other NSAIDs but differs in its pharmacokinetic profile, dosing frequency, and gastrointestinal safety margin. Compared with agents like naproxen or diclofenac, ibuprofen often has a shorter half‑life, allowing flexible dosing but may require more frequent administration for sustained effect.

Ibuprofen Brillpharma should be stored at room temperature, below 25 °C, in its original container. Protect the product from moisture, direct sunlight, and extreme temperatures to maintain potency and stability throughout its shelf life.

The medication is taken orally, usually with a full glass of water. It can be taken with or without food, although taking it with meals may reduce stomach irritation. Follow the prescriber’s guidance on timing and frequency.

Serious risks include gastrointestinal bleeding or ulceration, severe allergic reactions such as anaphylaxis, acute kidney injury, liver dysfunction, and increased cardiovascular events like heart attack or stroke, especially with high‑dose or prolonged use.

Individuals with known hypersensitivity to ibuprofen or other NSAIDs, active gastrointestinal ulcers, severe heart failure, uncontrolled hypertension, or those on anticoagulant therapy without close monitoring should avoid this medication. Consultation with a healthcare professional is essential before use.